Management of cerebral vasculopathy in children with sickle cell anaemia

British Journal of Haematology

Volumn 108, Issue 4, 2000, Pages 666-678

  Powars, Darleen R ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Cerebral ischaemia; Cognitive impairment; Neuroprotective; Sickle cell anaemia

Indexed keywords

BRAIN INFARCTION; BRAIN ISCHEMIA; CEREBROVASCULAR DISEASE; CHILD; COGNITION; ERYTHROCYTE TRANSFUSION; HUMAN; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; RISK FACTOR; SICKLE CELL ANEMIA; STROKE;

ADOLESCENT; ADULT; ALGORITHMS; ANTISICKLING AGENTS; BLOOD TRANSFUSION; BONE MARROW TRANSPLANTATION; CEREBROVASCULAR ACCIDENT; CHILD; CHILD, PRESCHOOL; DATABASES, BIBLIOGRAPHIC; EVIDENCE-BASED MEDICINE; HUMANS; HYDROXYUREA; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; NEUROPROTECTIVE AGENTS; SICKLE CELL TRAIT; TOMOGRAPHY, EMISSION-COMPUTED; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; ULTRASONOGRAPHY, DOPPLER;

EID: 0034108095     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.2000.01912.x     Document Type: Review

References (114)

1. Aboud, M.R., Jackson, S.M., Barredo, J., Holden, K.R., Cure, J. & Laver, J. (1996) Neurologic complications following bone marrow transplantation for sickle cell disease. Bone Marrow Transplantation, 17, 405-407.
2. Adams, D.M., Shultz, W.H., Ware, R.E. & Kinney, T.R. (1996) Erythrocytapheresis can reduce iron overload and prevent the need for chelation therapy in chronically transfused pediatric patients. Journal of Pediatric Hematology/Oncology, 18, 46-50.
3. Adams, R., McKie, V., Nichols, F., Carl, E., Zhang, D.L., McKie, K., Figueroa, R., Litaker, M., Thompson, W. & Hess, D. (1992) The use of transcranial ultrasonography to predict stroke in sickle-cell disease. New England Journal of Medicine, 326, 605-610.
4. Adams, R.J., Kutlar, A., McKie, V., Carl, E., Nichols, F.T., Liu, J.C., McKie, K. & Clary, A. (1994) Alpha thalassemia and stroke risk in sickle cell anemia. American Journal of Hematology, 45, 279-282.
5. Adams, R.J., McKie, V.C., Carl, E.M., Nichols, F.T., Perry, R., Brock, K., McKie, K., Figueroa, R., Litaker, M., Weiner, M.S. & Brambilla, D. (1997) Long-term stroke risk in children with sickle cell disease screened with transcranial Doppler. Annals of Neurology, 42, 699-704.
6. Adams, R.J., McKie, V.C., Hsu, L., Files, B., Vinchinsky, E., Pegelow, C., Abboud, M., Gallagher, D., Kutlar, A., Nichols, F.T., Bonds, D.R. & Brambilla, D. (1998) Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial doppler ultrasonography. New England Journal of Medicine, 339, 5-11.
7. Adragna, N.C., Fonseca, P. & Lauf, P.K. (1994) Hydroxyurea affects cell morphology, cation transport, and red blood cell adhesion in cultured vascular endothelial cells. Blood, 83, 553-560.
8. Annobil, S.H., Omojola, M.F., Adzaku, F.K.,. Addae, S.K. & Mohammed, S. (1990) Cerebrovascular accidents (strokes) in children with sickle cell disease residing at high and low altitudes of Saudi Arabia. Annals of Tropical Paediatrics, 10, 191-198.
9. Armstrong, F.D., Thompson, Jr, R.J., Wang, W., Zimmerman, R., Pegelow, C.H., Miller, S., Moser, F., Bello, J., Hurtig, A., Vass, K. & the Neuropsychology Committee of the Cooperative Study of Sickle Cell Diseases. (1996) Cognitive functioning and brain magnetic resonance imaging in children with sickle cell disease. Pediatrics, 97, 864-870.
10. Balkaran, B., Char, G., Morris, J.S., Thomas, P.W., Serjeant, B.E. & Serjeant, G.R. (1992) Stroke in a cohort study of patients with homozygous sickle cell disease. Journal of Pediatrics, 120, 360-366.
11. Ballas, S.K., Marcolina, M.J., Dover, G.J. & Barton, F.B. (1999) Erythropoietic activity in patients with sickle cell anaemia before and after treatment with hydroxyurea. British Journal of Haematology, 105, 491-496.
12. Bernaudin, F. (1999) Resultats et indications actuelles de l'allogreffe de moelle dans la drepanocytose. |Results and current indications for allogeneic bone marrow grafting in sickle cell disease.| Pathologie et Biologie, 47, 59-64.
13. Bernaudin, F., Freard, F., Verlhac, S., Roudot-Thoraval, F., Benkerrou, M., Thuret, I., Mardini, R., Vannier, J.P., Ploix, E., Robero, M., Casse-Perrot, C., Helly, M., Gillard, E., Lesprit, E. & Brugieres, P. (1998) In sickle cell disease, overt and silent strokes, low hematocrit level and high platelet count, significantly and independently badly influence psychometric performances. Blood (Abstract), 92, 496a.
14. Brody, A.S., Embury, S.H., Mentzer, W.C., Wingkler, M.L. & Gooding, C.A. (1988) Preservation of sickle cell blood-flow patterns during MR imaging: an in vivo study. American Journal of Roentgenology, 151, 129-141.
15. Bronspiegel-Weintrob, N., Olivieri, N.F., Tyler, B., Andrews, D.F., Freedman, M.H. & Holland, F.J. (1990) Effect of age at the start of iron chelation therapy on gonadal function in β-thalassemia major. New England Journal of Medicine, 323, 713-719.
16. Buchanan, G.R., Bowman, W.P. & Smith, S.J. (1983) Recurrent cerebral ischemia during hypertransfusion therapy in sickle cell anemia. Journal of Pediatrics, 103, 921-923.
17. Bunn, H.F. (1999) Induction of fetal hemoglobin in sickle cell disease. Blood, 93, 1787-1789.
18. Charache, S., Barton, F.B., Moore, R.D., Terrin, M.L., Steinberg, M.H., Dover, G.J., Ballas, S.K., McMahon, R.P., Castro, O., Orringer, E.P. & Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia. (1996) Hydroxyurea and sickle cell anemia. Clinical utility of a myelosuppressive 'switching' agent. Medicine, 75, 300-326.
19. Chui, D. & Grotta, J. (1997) Current clinical status of cytoprotection. In: Primer on Cerebrovascular Diseases (ed. by K.M.A. Welch, L.R. Caplan, D.J. Reis, B.K. Siesjo & B. Weir), pp. 731-737. Academic Press, San Diego.
20. Cohen, A.R. (1998) Sickle cell disease - new treatments, new questions. New England Journal of Medicine, 339, 42-44.
21. Cohen, A.R., Martin, M.B., Silber, J.H., Kim, H.C., Frempong, K.O. & Schwartz, E. (1992) A modified transfusion program for prevention of stroke in sickle cell disease. Blood, 79, 1657-1661.
22. Craft, S., Schatz, J., Glauser, T.A., Lee, B. & DeBaun, M.R. (1993) Neuropsychologic effects of stroke in children with sickle cell anemia. Journal of Pediatrics, 123, 712-717.
23. DeBaun, M.R., Glauser, T.A., Siegel, M., Borders, J. & Lee, B. (1995) Noninvasive central nervous system imaging in sickle cell anemia. A preliminary study comparing transcranial doppler with magnetic resonance angiography. Journal of Pediatric Hematology/ Oncology, 17, 29-33.
24. DeBaun, M.R., Schatz, J., Siegel, M.J., Koby, M., Craft, S., Resar, L., Chu, J.Y., Launius, G., Dadash-Zadeh, M., Lee, R.B. & Noetzel, M. (1998) Cognitive screening examinations for silent cerebral infarcts in sickle cell disease. Neurology, 50, 1678-1682.
25. Ferster, A., Corazza, F., Vertongen, F., Bujan, W., Devalck, C., Fondu, P., Cochaux, P., Lambermont, M., Khaladji, Z. & Sariban, E. (1995) Transplanted sickle cell disease patients with autologous bone marrow recovery after graft failure develop increased levels of fetal haemoglobin which corrects disease severity. British Journal of Haematology, 90, 804-808.
26. Ferster, A., Vermylen, C., Cornu, G., Buyse, M., Corazza, F., Devalck, C., Fondu, P., Toppet, M. & Sariban, E. (1996) Hydroxyurea for treatment of severe sickle cell anemia: a pediatric clinical trial. Blood, 88, 1960-1964.
27. Figueiredo, M.S., Kerbauy, J., Goncalves, M.S., Arruda, V.R., Saad, S.T., Sonati, M.F., Stoming, T. & Costa, F.F. (1996) Effect of alpha-thalassemia and beta-globin gene cluster haplotypes on the hematological and clinical features of sickle-cell anemia in Brazil. American Journal of Hematology, 53, 72-76.
28. Garcia, J.H., Lassen, N.A., Weiller, C., Sperling, B. & Nakagawara, J. (1996) Ischemic stroke and incomplete infarction. Stroke, 27, 761-765.
29. Gillams, A.R., McMahon, L., Weinberg, G. & Carter, A.P. (1998) MRA of the intracranial circulation in asymptomatic patients with sickle cell disease. Pediatric Radiology, 28, 283-287.
30. Glauser, T.A., Siegel, M.J., Lee, B.C.P. & De Baun, M.R. (1995) Accuracy of neurologic examination and history in detecting evidence of MRI-diagnosed cerebral infarctions in children with sickle cell hemoglobinopathy. Journal of Child Neurology, 10, 88-92.
31. Goncalves, M.S., Nechtman, J.F., Figueiredo, M.S., Kerbauy, J., Arruda, V.R., Sonati, M.F., Saad, S.O., Costa, F.F. & Stoming, T.A. (1994) Sickle cell disease in a Brazilian population from Sao Paulo: a study of the beta s haplotypes. Human Heredity, 44, 322-327.
32. Goto, Y. & Yonekawa, Y. (1992) Worldwide distribution of moyamoya disease. Neurologie Medicale Chirurgie, 32, 883-886.
33. Grotta, J. for the US and Canadian Lubeluzole Ischemic Stroke Study Group. (1997) Lubeluzole treatment for acute ischemic stroke. Stroke, 28, 2338-2546.
34. Grubb, R.L., Derdeyn, C.P., Fritsch, S.M., Carpenter, D.A., Yundt, K.D., Videen, T.O., Spitznagel, E.L. & Powers, W.J. (1998) Importance of hemodynamic factors in the prognosis of symptomatic carotid occlusion. Journal of the American Medical Association, 280, 1055-1060.
35. Hariman, L.M.F., Griffith, E.R., Hurtig, A.L. & Keehn, M.T. (1991) Functional outcomes of children with sickle-cell disease affected by stroke. Archives of Physics and Medical Rehabilitation, 72, 498-502.
36. Hebbel, R.P. (1997) Perspectives series: cell adhesion in vascular biology. Adhesive interactions of sickle erythrocytes with endothelium. Journal of Clinical Investigations, 99, 2561-2564.
37. Herold, S., Brozovic, M., Gibbs, J., Lammertsma, A.A., Leenders, K.L., Carr, D., Fleming, J.S. & Jones, T. (1986) Measurement of regional cerebral blood flow, blood volume and oxygen metabolism in patients with sickle cell disease using positron emission tomography. Stroke, 17, 692-698.
38. Hickenbottom, S.L. & Grotta, J. (1998) Neuroprotective therapy. Seminars in Neurology, 18, 485-492.
39. Hurlet-Jensen, A.M., Prohovnik, I., Pavlakis, S.G. & Piomelli, S. (1994) Effects of total hemoglobin and hemoglobin S concentration on cerebral blood flow during transfusion therapy to prevent stroke in sickle cell disease. Stroke, 25, 1688-1692.
40. Jayabose, S., Tugal, O., Sandoval, C., Patel, P., Puder, D., Lin, T. & Visintainer, P. (1996) Clinical and hematologic effects of hydroxyurea in children with sickle cell anemia. Journal of Pediatrics, 129, 559-565.
41. Johnson, F.L., Mentzer, W.C., Kalinyak, K.A., Sullivan, K.M. & Abboud, M.R. (1994) Bone marrow transplantation for sickle cell disease. The United States experience. American Journal of Pediatric Hematology/Oncology, 16, 22-26.
42. Kalinyak, K.A., Morris, C., Ball, W.S., Ris, M.D., Harris, R. & Rucknagel, D. (1995) Bone marrow transplantation in a young child with sickle cell anemia. American Journal of Hematology, 48, 256-261.
43. Kandeel, A.Y., Zimmerman, R.A. & Ohene-Frempong, K. (1996) Comparison of magnetic resonance angiography and conventional angiography in sickle cell disease: clinical significance and reliability. Neuroradiology, 38, 409-416.
44. Kinney, T.R., Sleeper, L.A., Wang, W.C., Zimmerman, R.A., Pegelow, C.H., Ohene-Frempong, K., Wethers, D.L., Bello, J.A., Vichinsky, E.P., Moser, F.G., Gallagher, D.M., DeBaun, M.R., Platt, O.S. & Miller, S.T. and the Cooperative Study of Sickle Cell Disease. (1999) Silent cerebral infarcts in sickle cell anemia: a risk factor analysis. Pediatrics, 103, 640-645.
45. Klijn, C.M.J., Kappelle, L.J., Tulleken, C.A.F. & van Gijn, J. (1997) Symptomatic carotid artery occlusion: a reappraisal of hemodynamic factors. Stroke, 28, 2084-2093.
46. Kogutt, M.S., Goldwag, S.S., Gupta, K.L., Kaneko, K. & Humbert, J.R. (1994) Correlation of transcranial doppler ultrasonography with MRI and MRA in the evaluation of sickle cell disease patients with prior stroke. Pediatric Radiology, 24, 204-206.
47. Koshy, M., Chinnamma, T. & Goodwin, J. (1990) Vascular lesions in the central nervous system in sickle cell disease (neuropathology). Journal of the Associated Academy of Minority Physiologists, 1, 71-78.
48. Kugler, S., Anderson, B., Cross, D., Sharif, Z., Sano, M., Haggerty, R., Prohovnik, I., Hurlet-Jensen, A., Hilal, S. & Mohr, J.P. (1993) Abnormal cranial magnetic resonance imaging scans in sickle-cell disease. Neurological correlates and clinical implications. Archives of Neurology, 50, 629-635.
49. Liesner, R., Mackie, I., Cookson, J., McDonald, S., Chitolie, A., Donohoe, S., Evans, J., Hann, I. & Machin, S. (1998) Prothrombotic changes in children with sickle cell disease: relationships to cerebrovascular disease and transfusion. British Journal of Haematology, 103, 1037-1044.
50. Maier-Redelsperger, M., de Montalembert, M., Flahault, A., Neonato, M.G., Ducrocq, R., Masson, M.P., Girot, R. & Jacques Elion for the French Study Group on Sickle Cell Disease. (1998) Fetal hemoglobin and F-cell responses to long-term hydroxyurea treatment in young sickle cell patients. Blood, 91, 4472-4479.
51. Mendelowitsch, A., Sekhar, L.N., Clemente, R. & Shuaib, A. (1997) EC-IC bypass improves chronic ischemia in a patient with moyamoya disease secondary to sickle cell disease: an in vivo microdialysis study. Neurological Research, 19, 66-70.
52. Mercuri, E., Faundez, J.C., Roberts, I., Flora, S. & Bouza, H. (1995) Neurological 'soft' signs may identify children with sickle cell disease who are at risk for stroke. European Journal of Pediatrics, 154, 150-156.
53. Miller, S.T., Jensen, D. & Rao, S.P. (1992) Less intensive long-term transfusion therapy for sickle cell anemia and cerebrovascular accident. Journal of Pediatrics, 120, 54-57.
54. Miller, S.T., Sleeper, L.A., Pegalow, C.H., Enos, L.E., Wang, W.C., Weiner, S.J., Wethers, D.L., Smith, J.J. & Kinney, T.R. (2000) Prediction of adverse outcomes in children with sickle cell disease: a report from the cooperative study (CSSCD). New England Journal of Medicine, 342, 83-89.
55. de Montalembert, M., Beauviais, P., Bachir, D., Galacteros, F. & Girot, R. (1993) Cerebrovascular accidents in sickle cell disease. Risk factors and blood transfusion influence. French Study Group on Sickle Cell Disease. European Journal of Pediatrics, 152, 201-204.
56. Moser, F.G., Miller, S.T., Bello, J.A., Pegelow, C.H., Zimmerman, R.A., Wang, W.C., Ohene-Frempong, K., Schwartz, A., Vichinsky, E.P., Gallagher, D. & Kinney, T.R. (1996) The spectrum of brain MR abnormalities in sickle-cell disease: a report from the Cooperative Study of Sickle Cell Disease. American Journal of Neuroradiology, 17, 965-972.
57. Muir, K.W. & Lees, K.R. (1995) A randomized, double-blind, placebo-controlled pilot trial of intravenous magnesium sulfate in acute stroke. Stroke, 26, 1183-1188.
58. Novotny, E., Ashwal, S. & Shevell, M. (1998) Proton magnetic resonance spectroscopy: an emerging technology in pediatric neurology research. Pediatric Research, 44, 1-10.
59. Numaguchi, Y., Haller, J.S., Humbert, J.R., Robinson, A.E., Lindstrom, W.W., Gruenauer, L.M. & Carey, J.E. (1990) Cerebral blood flow mapping using stable xenon-enhanced CT in sickle cell cerebrovascular disease. Neuroradiology, 32, 289-295.
60. Ohene-Frempong, K., Weiner, S.J., Sleeper, L.A., Miller, S.T., Embury, S., Moohr, J.W., Wethers. D.L., Pegelow, C.H., Gill, F.M. & the Cooperative Study of Sickle Cell Disease. (1998) Cerebrovascular accidents in sickle cell disease: rates and risk factors. Blood, 91, 288-294.
61. Olivieri, N.F. & Vichinsky, E.P. (1998) Hydroxyurea in children with sickle cell disease: impact on splenic function and compliance with therapy. Journal of Pediatric Hematology/Oncology, 20, 26-31.
62. Ozsoylu, S. & Altinoz, N. (1977) Sickle-cell anaemia in Turkey. Evaluation of 97 cases (with parents' findings). Scandinavian Journal of Haematology, 19, 85-92.
63. Pegelow, C.H., Adams, R.J., McKie, V., Abbound, M., Berman, B., Miller, S.T., Oliveieri, N., Vichensky, E., Wang, W. & Brambilla, D. (1995) Risk of recurrent stroke in patients with sickle cell disease treated with erythrocyte transfusions. Journal of Pediatrics, 126, 896-899.
64. Perrine, R.P., Pembrey, M.E., John, P., Perrine, S. & Shoup, F. (1978) Natural history of sickle cell anemia in Saudi Arabs. Annals of Internal Medicine, 88, 1-6.
65. Platt, O.S., Brambilla, D.J., Rosse, W.F., Milner, P.F., Castro, O., Steinberg, M.H. & Klugg, P.P. (1994) Mortality in sickle cell disease. Life expectancy and risk factors for early death. New England Journal of Medicine, 330, 1639-1644.
66. Powars, D.R., Wilson, B., Imbus, C., Pegelow, C. & Allen, J. (1978) The natural history of stroke in sickle cell disease. American Journal of Medicine, 65, 461-471.
67. Powars, D.R., Weiss, J.N., Chan, L.S. & Schroeder, W.A. (1984) Is there a threshold level of fetal hemoglobin which ameliorates morbidity in sickle cell anemia? Blood, 63, 921-926.
68. Powars, D., Adams, R.J., Nichols, F.T., Milner, P., Charache, S. & Sarnaik, S. (1990a) Delayed intracranial hemorrhage following cerebral infarction in sickle cell anemia. Journal of the Associated Academy of Minority Physiologists, 1, 79-82.
69. Powars, D., Chan, L.S. & Schroeder, W.A. (1990b) The variable expression of sickle cell diseases is genetically determined. Seminars in Hematology, 27, 360-376.
70. Powars, D.R., Conti, P.S., Wong, W.Y., Groney, P., Hyman, C., Smith, E., Ewing, N., Keenan, R.N., Zee, C.S., Harold, Y., Hiti, A.L., Teng, E.L. & Chan, L.S. (1999) Cerebral vasculopathy in sickle cell anemia: diagnostic contribution of positron emission tomography. Blood, 93, 71-79.
71. Prohovnik, I., Pavlakis, S.G., Piomelli, S., Bello. J., Bohr, J.P., Hilal, S. & De Vivo, D.C. (1989) Cerebral hyperemia, stroke and transfusion in sickle cell disease. Neurology, 39, 344-348.
72. Rackoff, W.R., Ohene-Frempong, K., Month, S., Scott, J.P., Neahring, B. & Cohen, A.R. (1992) Neurologic events after partial exchange transfusion for priapism in sickle cell disease. Journal of Pediatrics, 120, 882-885.
73. Rana, S., Houston, P.E., Surana, N., Shalaby-Rana, E.I. & Castro, O.L. (1997) Discontinuation of long-term transfusion therapy in patients with sickle cell disease and stroke. Journal of Pediatrics, 131, 757-760.
74. Reed, W., Jagust, W., Al-Mateen, M. & Vichinsky, E. (1999) Role of positron emission tomography in determining the extent of CNS ischemia in patients with sickle cell disease. American Journal of Hematology, 60, 268-272.
75. Rodgers , G.P., Clark, C.M., Larson, S.M., Rapaport, S.I., Nienhuis, A.W. & Schecter, A.N. (1988) Brain glucose metabolism in neurologically normal patients with sickle cell disease. Regional alterations. Archives of Neurology, 45, 78-82.
76. Rosse, W.R., Gallagher, D., Kinney, T.R., Castro, O., Dosik, H., Moohr, I., Wang, W., Levy, P.S. and the Cooperative Study of Sickle Cell Disease. (1990) Transfusion and alloimmunization in sickle cell disease. Blood, 76, 1431-1437.
77. Russell, M.O., Goldberg, H.I., Hodson, A., Kim, H.C., Halus, J., Reivich, M. & Schwartz, E. (1984) Effect of transfusion therapy on arteriographic abnormalities and on recurrence of stroke in sickle cell disease. Blood, 63, 162-169.
78. Sarnaik, S.A. (1998) Prevention of stroke by transfusions in children with sickle cell anemia. New England Journal of Medicine, 339, 1477-1478.
79. Sarnaik, S., Soorya, D., Kim, J., Ravindranath, Y. & Lusher, J. (1979) Periodic transfusions for sickle cell anemia and CNS infarction. American Journal of Diseases in Children, 133, 1254-1257.
80. Scott, J.P., Hillery, C.A., Brown, E.R., Misiewicz, V. & Labotka, R.J. (1996) Hydroxyurea therapy in children severely affected with sickle cell disease. Journal of Pediatrics, 128, 820-828.
81. Seibert, J.J., Miller, S.F., Kirby, R.S., Becton, D.L., James, C.A., Glasier, C.M., Wilson, A.R., Kinder, D.L. & Berry, D.H. (1993) Cerebrovascular disease in symptomatic and asymptomatic patients with sickle cell anemia: screening with duplex transcranial Doppler US - correlation with MR imaging and MR angiography. Radiology, 189, 457-466.
82. Seibert, J.J., Glasier, C.M., Kirby, R.S., Allison, J.W., James, C.A., Becton, D.L., Kinder, D.L., Cox, K.S., Flick, E.L., Lairry, F., Jackson, J.F. & Graves, R.A. (1998) Transcranial Doppler, MRA, and MRI as screening examination for cerebrovascular disease in patients with sickle cell anemia: an 8-year study. Pediatric Radiology, 28, 138-142.
83. Serjeant, G. (1997) Chronic transfusion programmes in sickle cell disease: problem or panacea? British Journal of Haematology, 97, 253-255.
84. Sotty, B.N. & Stuart, M.J. (1996) Vascular cell adhesion molecule-1 is involved in mediating hypoxia-induced sickle red blood cell adherence to endothelium: potential role in sickle cell disease. Blood, 88, 2311-2320.
85. Siegel, M.J., Luker, G.D., Glauser, T.A. & DeBaun, M.R. (1995) Cerebral infarction in sickle cell disease: transcranial Doppler US versus neurologic examination. Radiology, 197, 191-194.
86. Silliman, C.C., Peterson, V.M., Mellman, D.L., Dixon, D.J., Hambidge, K.M. & Lane, P.A. (1993) Iron chelation by deferoxamine in sickle cell patients with severe transfusion-induced hemosiderosis: a randomized, double-blind study of the dose-response relationship. Journal of Laboratory and Clinical Medicine, 122, 48-54.
87. Steen, R.G., Reddick, W.E., Mulhern, R.K., Langston, J.W., Ogg, R.J., Bieberich, A.A., Kingsley, P.B. & Wang, W.C. (1998) Quantitative MRI of the brain in children with sickle cell disease reveals abnormalities unseen by conventional MRI. Journal of Magnetic Resonance Imaging, 8, 535-543.
88. Steen, R.G., Langston, J.W., Ogg, R.J., Xiong, X., Ye, Z. & Wang, W.C. (1999) Diffuse T1 reduction in gray matter of sickle cell disease patients: evidence of selective vulnerability to damage? Magnetic Resonance Imaging, 17, 503-515.
89. Steinberg, M.H., Lu, Z.H., Barton, F.B., Terrin, M.L., Charache, S., Dover, G.J. and the Multicenter Study of Hydroxyurea. (1997) Fetal hemoglobin in sickle cell anemia: determinants of response to hydroxyurea. Multicenter study of hydroxyurea. Blood, 89, 1078-1088.
90. Stins, M.F., Gilles, F. & Kim, K.S. (1997) Selective expression of adhesion molecules on human brain microvascular endothelial cells. Journal of Neuroimmunology, 76, 81-90.
91. Sultana, C., Shen, Y., Rattan, V., Johnson, C. & Kalra, V.K. (1998) Interaction of sickle erythrocytes with endothelial cells in the presence of endothelial cell conditioned medium induces oxidant stress leading to transendothelial migration of monocytes. Blood, 92, 3924-3935.
92. Swift, A.V., Cohen, M.J., Hynd, G.W., Wisenbaker, J.M., McKie, K.M., Makari, G. & McKie, V.C. (1989) Neuropsychologic impairment in children with sickle cell anemia. Pediatrics, 84, 1077-1085.
93. Ueki, K., Meyer, F.B. & Mellinger, J.F. (1994) Moyamoya Disease: the disorder and surgical treatment. Mayo Clinical Proceedings, 67, 749-757.
94. Valles, J., Santos, M.L. Aznar, J., Osa, A., Lago, A., Cosin, J., Sanchez, E., Broekman, M.J. & Marcus, A.J. (1998) Erythrocyte promotion of platelet reactivity decreases the effectiveness of aspirin as an antithrombotic therapeutic modality: the effect of low-dose aspirin is less than optimal in patients with vascular disease due to prothrombotic effects of erythrocytes on platelet reactivity. Circulation, 97, 350-355.
95. Venketasubramanian, N., Prohovnik, I., Hurlet, A., Mohr, J.P. & Piomelli, S. (1994) Middle cerebral artery velocity changes during transfusion in sickle cell anemia. Stroke, 25, 2153-2158.
96. Verlhac, S. (1999) Imaging of cerebrovascular disease in sickle cell anemia. Pathologie et Biologie, 47, 31-38.
97. Verlhac, S., Bernaudin, F., Tortrat, D., Brugieres, P., Mage, K., Gaston, A. & Reinert, P. (1995) Detection of cerebrovascular disease in patients with sickle cell disease using transcranial Doppler sonography: correlation with MRI, MRA and conventional angiography. Pediatric Radiology, 25, 14-19.
98. Vermylen, C. & Cornu, G. (1994) Bone marrow transplantation for sickle cell disease. The European experience. American Journal of Pediatric Hematology/Oncology, 16, 18-21.
99. Vernet, O., Montes, J.L., O'Gorman, A.M., Baruchel, S. & Farmer, J.P. (1996) Encephaloduroarterio-synangiosis in a child with sickle cell anemia and moyamoya disease. Pediatric Neurology, 14, 226-230.
100. Vichinsky, E.P. & Lubin, B.H. (1994) A cautionary note regarding hydroxyurea in sickle cell disease. Blood, 83, 1124-1128.
101. Walters, M.C., Sullivan, K.M., Bernaudin, F., Souillet, G., Vannier, J.P., Johnson, F.L., Lenarsky, C., Powars, D., Bunin, N., Ohene-Frempong, K., Wall, D., Michel, G., Plouvier, M.E., Bodigoni, P., Lutz, P., Sanders, J.E., Matthews, D.C., Patience, M., Appelbaum, F.R. & Stork, R. (1995) Neurologic complications after allogeneic marrow transplantation for sickle cell anemia. Blood, 85, 879-884.
102. Walters, M.C., Patience, M., Leisenring, W., Rogers, Z.R., Dinndorf, P., Davies, S.C., Roberts, I.A.G., Yeager, A., Kurtzberg, J., Bunin, N., Scott, J.P., Wall, D.A., Wayne, A.S., Wiley, J., Darbyshire, P.J., Mentzer, W.C., Smith, F.O. & Sullivan, K.M. (1997) Collaborative multicenter investigation of marrow transplantation for sickle cell disease: current results and future directions. Biological Bone Marrow Transplantation, 3, 310-315.
103. Wang, W.C., Kovnar, E.H., Tonkin, I.L., Mulhern, R.K., Langston, J.W., Day, S.W., Schell, M.J. & Wilimas, J.A. (1991) High risk of recurrent stroke after discontinuance of five to twelve years of transfusion therapy in patients with sickle cell disease. Journal of Pediatrics, 118, 377-382.
104. Wang, W.C., Grover, R., Gallagher, D., Espeland, M. & Fandal, A. (1993) Developmental screening in young children with sickle cell disease. Results of a cooperative study. American Journal of Pediatric Hematology/Oncology, 15, 87-91.
105. Wang, W.C., Riester, K., Gallagher, D., Thompson, R., Guarini, L., Vichinsky, E., Wright, E. & Armstrong, D. (1998a) Neuropsychometric performance declines with age in children with sickle cell disease: a report from the cooperative study of sickle cell disease (CSSCD) (Abstract). Blood, 92, 496a.
106. Wang, W.C., Langston, J.W., Steen, R.G., Wynn, L.W., Mulbern, R.K., Wilimas, J.A., Kim, F.M. & Figueroa, R.E. (1998b) Abnormalities of the central nervous system in very young children with sickle cell anemia. Journal of Pediatrics, 132, 994-998.
107. 3H nuclear magnetic resonance spectroscopy. Neuroradiology, 35, 57-65.
108. Wang, Z., Zimmerman, R.A. & Sauter, R. (1996) Proton MR spectroscopy of the brain: clinically useful information obtained in assessing CNS diseases in children. American Journal of Roentgenology, 167, 191-199.
109. Ware, R.E., Zimmerman, S.A. & Schultz, W.-H. (1999) Hydroxyurea: an alternative to blood transfusions for the prevention of recurrent stroke in children with sickle cell disease. Blood, 94, 3022-3026.
110. Wasserman, A.L., Wilimas, J.A., Fairclough, D.L., Mulhern, R.K. & Wang, W. (1991) Subtle neuropsychologic deficits in children with sickle cell disease. American Journal of Pediatric Hematology/ Oncology, 13, 14-20.
111. Watkins, K.E., Hewes, K.D., Connelly, A., Kendall, B.E., Kingsley, D.P., Evans, J.E., Gadian, D.G., Vargha-Khadem, F. & Kirkham, F.J. (1998) Cognitive deficits associated with frontal-lobe infarction in children with sickle cell disease. 40, 536-543.
112. Wilimas, J., Goff, J.R., Anderson, Jr. H.R., Langston, J.W. & Thompson, E. (1980) Efficacy of transfusion therapy for one to two years in patients with sickle cell disease and cerebrovascular accidents. Journal of Pediatrics, 96, 205-209.
113. Yamauchi, H., Fukuyama, Y., Nagahama, Y., Nabatame, H., Nakamura, K., Yamamoto, Y., Yonekura, Y., Konishi, J. & Kimura, J. (1996) Evidence of misery perfusion and risk for recurrent stroke in major cerebral arterial occlusive diseases from PET. Journal of Neurology Neurosurgery and Psychiatry, 61, 18-25.
114. Zimmerman, R.A., Gill, F., Goldberg, H.I., Bilaniuk, L.T., Hackney, D.B., Johnson, M., Grossman, R.I. & Hecht-Leavitt, C. (1987) MRI of sickle cell cerebral infarction. Neuroradiology, 29, 232-237.